Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Remdesivir
Cancer
Approved by FDA Experimental Antiviral Jan/18/2023
BNT162b2
Cancer
Approved by FDA Experimental Vaccine Jun/22/2022
Convalescent plasma
Cancer
Emergency use authorization Experimental Antiviral May/16/2022
Baricitinib
Cancer
Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Tocilizumab
Cancer
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Ruxolitinib
Cancer
Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021
Toremifene
Cancer
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/28/2020